Locally Advanced Malignant Neoplasm
41
2
7
19
Key Insights
Highlights
Success Rate
76% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.6%
6 terminated out of 41 trials
76.0%
-10.5% vs benchmark
15%
6 trials in Phase 3/4
26%
5 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (41)
Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy
Financial Distress in Advanced Cancer Patients
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits
Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment
Microbiome and Rectal Cancer
Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Olaparib and Radiotherapy in Inoperable Breast Cancer
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer